KLRS

Kalaris Therapeutics, Inc. Common Stock
KLRS

Overview Fund Activity

94 hedge funds and large institutions have $184M invested in Kalaris Therapeutics, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 47 increasing their positions, 18 reducing their positions, and 10 closing their positions.

Holders
94
Holders Change
+5
Holders Change %
+5.62%
% of All Funds
1.48%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
47
Reduced
18
Closed
10
Calls
$172K
Puts
$221K
Net Calls
-$49K
Net Calls Change
-$233K

Top Buyers

1
WA
1
Wasatch Advisors
Utah
$22.6M
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$32.4M
3
AG
3
Artal Group
Luxembourg
$22.4M
4
GC
4
GMT Capital
Georgia
$14M
5
MS
5
Maven Securities
Jersey
$2.5M

Top Sellers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$9.15M
2
Renaissance Technologies
2
Renaissance Technologies
New York
$1.04M
3
AA
3
ALPS Advisors
Colorado
$0
4
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
$791K
5
State of Wisconsin Investment Board
5
State of Wisconsin Investment Board
Wisconsin
$315K
Name Holding Trade Value Shares
Change 		Shares
Change %
Prudential Financial
101
Prudential Financial
New Jersey
– -$57.9K -639 Closed
Manulife (Manufacturers Life Insurance)
102
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$54K -596 Closed
Simplex Trading
103
Simplex Trading
Illinois
– -$9K -107 Closed
QCG
104
Quadrant Capital Group
Ohio
– -$1.37K -15 Closed
1 2 3 4
5